Overall trends from studies in patients with newly diagnosed breast tumors indicate that circulating plasma M-CSF levels are not higher in patients with localized tumors than in controls, but are elevated in patients with regionally advanced disease and distant metastases (70, 71). The gene discussed is CSF1; the disease is breast neoplasm.